|
ZKSCAN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.37210000320465E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.519800E-03 |
| Normal-vs-Stage2 |
9.447600E-04 |
| Normal-vs-Stage3 |
5.50030021528869E-11 |
| Normal-vs-Stage4 |
9.59660018118313E-10 |
| Stage1-vs-Stage2 |
9.445700E-02 |
| Stage1-vs-Stage3 |
2.43789999998523E-06 |
| Stage1-vs-Stage4 |
2.08779999999464E-05 |
| Stage2-vs-Stage3 |
1.408630E-01 |
| Stage2-vs-Stage4 |
1.336970E-01 |
| Stage3-vs-Stage4 |
8.666000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65660000162049E-08 |
| Normal-vs-AfricanAmerican |
2.062000E-02 |
| Normal-vs-Asian |
3.646400E-01 |
| Caucasian-vs-AfricanAmerican |
3.726000E-01 |
| Caucasian-vs-Asian |
7.062200E-03 |
| AfricanAmerican-vs-Asian |
5.456300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.84840004308273E-09 |
| Normal-vs-Female |
1.320810E-03 |
| Male-vs-Female |
1.561820E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.896200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.240600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.04459996208561E-09 |
| Normal-vs-Age(81-100Yrs) |
1.8193999995475E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.928800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.254100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.472300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.557200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.305700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.775010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.505600E-01 |
| Normal-vs-Grade 2 |
3.118900E-03 |
| Normal-vs-Grade 3 |
9.90210002882463E-09 |
| Normal-vs-Grade 4 |
2.17825757431456E-12 |
| Grade 1-vs-Grade 2 |
1.381940E-02 |
| Grade 1-vs-Grade 3 |
1.443530E-02 |
| Grade 1-vs-Grade 4 |
2.276900E-03 |
| Grade 2-vs-Grade 3 |
4.640800E-03 |
| Grade 2-vs-Grade 4 |
1.32980000011607E-07 |
| Grade 3-vs-Grade 4 |
4.076200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.699300E-03 |
| Normal-vs-ccB subtype |
2.07230000048853E-07 |
| ccA subtype-vs-ccB subtype |
5.821800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64802000000019E-05 |
| Normal-vs-N1 |
9.116000E-03 |
| N0-vs-N1 |
2.392000E-01 |
|
|
